Assembly Biosciences, Inc. (ASMB)
37.05
+1.67
(+4.72%)
USD |
NASDAQ |
Dec 09, 12:04
Assembly Biosciences EPS Diluted (Quarterly): -0.7249 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Arvinas, Inc. | -0.4795 |
| Supernus Pharmaceuticals, Inc. | -0.7978 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.196M |
| Revenue (Quarterly) | 10.79M |
| Total Expenses (Quarterly) | 19.98M |
| Enterprise Value | 329.81M |
| Gross Profit Margin (Quarterly) | 99.70% |
| Profit Margin (Quarterly) | -85.24% |
| Earnings Yield | -12.96% |
| Normalized Earnings Yield | -12.96 |